摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dibenzyl tartrate | 896448-46-7

中文名称
——
中文别名
——
英文名称
dibenzyl tartrate
英文别名
dibenzyl meso-tartrate;(+/-)-Weinsaeure-dibenzylester;meso-Weinsaeure-dibenzylester;dibenzyl (2R,3S)-2,3-dihydroxybutanedioate
dibenzyl tartrate化学式
CAS
896448-46-7
化学式
C18H18O6
mdl
——
分子量
330.337
InChiKey
LCKIPSGLXMCAOF-IYBDPMFKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    24
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    93.1
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    dibenzyl tartrate过碘酸 作用下, 以 乙醚 为溶剂, 反应 1.5h, 生成 苄基2-氧代乙酸酯
    参考文献:
    名称:
    Selection of a 2-azabicyclo[2.2.2]octane-based α4β1 integrin antagonist as an inhaled anti-asthmatic agent
    摘要:
    The alpha(4)beta(1) integrin, expressed on eosinophils and neutrophils, induces inflammation in the lung by facilitating cellular infiltration and activation. From a number of potent alpha(4)beta(1) antagonists that we evaluated for safety and efficacy, 1 was selected as a lead candidate for anti-asthma therapy by the inhalation route. We devised an optimized stereoselective synthesis to facilitate the preparation of a sufficiently large quantity of 1 for assessment in vivo. Administration of 1 to allergen-sensitive sheep by inhalation blocked the late-phase response of asthma and abolished airway hyper-responsiveness at 24 h following the antigen challenge. Additionally, the recruitment of inflammatory cells into the lungs was inhibited. Administration of 1 to ovalbumin-sensitized guinea pigs intraperitoneally blocked airway resistance and inhibited the recruitment of inflammatory cells. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2006.01.067
  • 作为产物:
    描述:
    erythraric acid苯甲醇对甲苯磺酸 作用下, 以 甲苯 为溶剂, 以64%的产率得到dibenzyl tartrate
    参考文献:
    名称:
    二醇的选择性单酰化和二不对称Desymmetrization观-Tartrates使用2-吡啶基酯作为酰化剂和金属羧酸盐作为催化剂
    摘要:
    用2-吡啶基苯甲酸酯作为酰化剂和Zn(OAc)2作为催化剂,1,2-二醇,1,3-二醇和邻苯二酚被选择性地单酰化。此外,首次实现了酒石酸内消旋酒石酸酯的高对映选择性去对称化,这是通过在CH 3 CN中使用2-吡啶基酯和NiBr 2 / AgOPiv / Ph-BOX或在EtOAc催化剂体系中使用CuCl 2 / AgOPiv / Ph-BOX来实现的(对等)到96%ee)。后者的催化剂体系,也是有效的苄动力学拆分DL -酒石酸盐。
    DOI:
    10.1021/acs.joc.9b00827
点击查看最新优质反应信息

文献信息

  • Hydrogenolysis of Benzyl Esters with Palladiumon-Carbon Catalysts
    作者:Harold L. Smith、Earle S. Brown、J. Doyle Smith、John Andrako
    DOI:10.1002/jps.2600540909
    日期:1965.9
    stereospecific sites on palladized charcoal hydrogenation catalysts have been made. The rates of hydrogenation of the benzyl esters of (+), (−), (±), and meso -tartaric acids, (±) malic acid, d -, l -, and dl -aspartic acids were measured. The rates were observed to be identical for the benzyl esters of the tartaric acids and the malic acid, indicating the possibility that these five substrates can utilize the
    进行了进一步的研究以证明在钯制木炭加氢催化剂上可能存在底物和立体特异性位点。测定了(+),(-),(±)和内消旋酒石酸,(±)苹果酸,d-,l-和dl-天冬氨酸的苄酯的氢化率。观察到酒石酸和苹果酸的苄基酯的速率相同,表明这五个底物可以利用相同的催化位点进行脱苄基作用的可能性。假定一个羟基和两个羰基苄氧基参与了催化剂-底物的复合物。当彼此比较时,二苄基天冬氨酸以相同的速率进行脱苄基作用。当与这些其他物质的速率相比时,发现琥珀酸二苄酯的氢解速率显着不同。不含羟基或氨基的琥珀酸二苄酯不会被期望利用与酒石酸,苹果酸和天冬氨酸的二苄酯相同的位点。
  • SATURATED FUSED [1,2-b]PYRIDAZINONE COMPOUNDS
    申请人:Ruebsam Frank
    公开号:US20080214529A1
    公开(公告)日:2008-09-04
    The invention is directed to saturated fused [1,2-b]pyridazinone compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.
    本发明涉及饱和融合[1,2-b]吡啶嗪化合物和含有这种化合物的制药组合物,其可用于治疗丙型肝炎病毒感染。
  • Selective Monoacylation of Diols and Asymmetric Desymmetrization of Dialkyl <i>meso</i>-Tartrates Using 2-Pyridyl Esters as Acylating Agents and Metal Carboxylates as Catalysts
    作者:Yuki Hashimoto、Chiaki Michimuko、Koki Yamaguchi、Makoto Nakajima、Masaharu Sugiura
    DOI:10.1021/acs.joc.9b00827
    日期:2019.7.19
    as a catalyst, 1,2-diols, 1,3-diols, and catechol were selectively monoacylated. Furthermore, the highly enantioselective desymmetrization of meso-tartrates was achieved for the first time, utilizing 2-pyridyl esters and NiBr2/AgOPiv/Ph-BOX in CH3CN or CuCl2/AgOPiv/Ph-BOX in EtOAc catalyst systems (up to 96% ee). The latter catalyst system was also effective for the kinetic resolution of dibenzyl dl-tartrate
    用2-吡啶基苯甲酸酯作为酰化剂和Zn(OAc)2作为催化剂,1,2-二醇,1,3-二醇和邻苯二酚被选择性地单酰化。此外,首次实现了酒石酸内消旋酒石酸酯的高对映选择性去对称化,这是通过在CH 3 CN中使用2-吡啶基酯和NiBr 2 / AgOPiv / Ph-BOX或在EtOAc催化剂体系中使用CuCl 2 / AgOPiv / Ph-BOX来实现的(对等)到96%ee)。后者的催化剂体系,也是有效的苄动力学拆分DL -酒石酸盐。
  • Selection of a 2-azabicyclo[2.2.2]octane-based α4β1 integrin antagonist as an inhaled anti-asthmatic agent
    作者:Edward C. Lawson、Rosemary J. Santulli、Alexey B. Dyatkin、Scott A. Ballentine、William M. Abraham、Sandra Rudman、Clive P. Page、Lawrence de Garavilla、Bruce P. Damiano、William A. Kinney、Bruce E. Maryanoff
    DOI:10.1016/j.bmc.2006.01.067
    日期:2006.6
    The alpha(4)beta(1) integrin, expressed on eosinophils and neutrophils, induces inflammation in the lung by facilitating cellular infiltration and activation. From a number of potent alpha(4)beta(1) antagonists that we evaluated for safety and efficacy, 1 was selected as a lead candidate for anti-asthma therapy by the inhalation route. We devised an optimized stereoselective synthesis to facilitate the preparation of a sufficiently large quantity of 1 for assessment in vivo. Administration of 1 to allergen-sensitive sheep by inhalation blocked the late-phase response of asthma and abolished airway hyper-responsiveness at 24 h following the antigen challenge. Additionally, the recruitment of inflammatory cells into the lungs was inhibited. Administration of 1 to ovalbumin-sensitized guinea pigs intraperitoneally blocked airway resistance and inhibited the recruitment of inflammatory cells. (c) 2006 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐